MicroRNA-29, a mysterious regulator in myocardial fibrosis and circulating miR-29a as a biomarker

Journal of the American College of Cardiology

Volumn 64, Issue 20, 2014, Pages 2181-

  Dai, Yao ^a   Dai, Dongsheng ^a   Mehta, Jawahar L ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; COLLAGEN; MICRORNA 29; MICRORNA 29A; PROTEIN BCL 2; PROTEIN CDC42; MICRORNA;

APOPTOSIS; CARDIAC REMODELING; CELL TRANSFORMATION; CELLULAR SECRETION; DOWN REGULATION; EXTRACELLULAR MATRIX; FIBROBLAST; GENE CONTROL; HEART; HEART DISEASE; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; ISCHEMIA; LETTER; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN SECRETION; UPREGULATION; BLOOD; FEMALE; GENETICS; HEART LEFT VENTRICLE HYPERTROPHY; MALE; PATHOLOGY;

BIOLOGICAL MARKERS; CARDIOMYOPATHY, HYPERTROPHIC; FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MICRORNAS;

EID: 84922567141     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.03.064     Document Type: Letter

References (5)

1. Roncarati R, Viviani Anselmi C, Losi MA, et al. Circulating miR-29a, among other up-regulated microRNAs, is the only biomarker for both hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2014;63:920-7.
2. Pekarsky Y, Santanam U, Cimmino A, et al. Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. Cancer Res 2006;66:11590-3.
3. Mott JL, Kobayashi S, Bronk SF, Gores GJ. Mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene 2007;26:6133-40.
4. Wang H, Garzon R, Sun H, et al. NF-kappaBYY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma. Cancer Cell 2008;14:369-81.
5. van Rooij E, Sutherland LB, Thatcher JE, et al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci U S A 2008;105:13027-32.